224 related articles for article (PubMed ID: 20178811)
21. The beneficial effects of angiotensin-converting enzyme II (ACE2) activator in pulmonary hypertension secondary to left ventricular dysfunction.
Chen IC; Lin JY; Liu YC; Chai CY; Yeh JL; Hsu JH; Wu BN; Dai ZK
Int J Med Sci; 2020; 17(16):2594-2602. PubMed ID: 33029102
[TBL] [Abstract][Full Text] [Related]
22. Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension.
de Man FS; Tu L; Handoko ML; Rain S; Ruiter G; François C; Schalij I; Dorfmüller P; Simonneau G; Fadel E; Perros F; Boonstra A; Postmus PE; van der Velden J; Vonk-Noordegraaf A; Humbert M; Eddahibi S; Guignabert C
Am J Respir Crit Care Med; 2012 Oct; 186(8):780-9. PubMed ID: 22859525
[TBL] [Abstract][Full Text] [Related]
23. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
[TBL] [Abstract][Full Text] [Related]
24. Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.
Jessup JA; Gallagher PE; Averill DB; Brosnihan KB; Tallant EA; Chappell MC; Ferrario CM
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2166-72. PubMed ID: 16766648
[TBL] [Abstract][Full Text] [Related]
25. Tsantan Sumtang attenuated chronic hypoxia-induced right ventricular structure remodeling and fibrosis by equilibrating local ACE-AngII-AT1R/ACE2-Ang1-7-Mas axis in rat.
Dang Z; Su S; Jin G; Nan X; Ma L; Li Z; Lu D; Ge R
J Ethnopharmacol; 2020 Mar; 250():112470. PubMed ID: 31862407
[TBL] [Abstract][Full Text] [Related]
26. [Effect of tanshinone II(A) on expression of different components in renin-angiotensin system of left ventricles of hypertensive rats].
Yu LZ; Shi CR
Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(8):1468-72. PubMed ID: 25039184
[TBL] [Abstract][Full Text] [Related]
27. Intrapulmonary activation of the angiotensin-converting enzyme type 2/angiotensin 1-7/G-protein-coupled Mas receptor axis attenuates pulmonary hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
Hampl V; Herget J; Bíbová J; Baňasová A; Husková Z; Vaňourková Z; Jíchová Š; Kujal P; Vernerová Z; Sadowski J; Červenka L
Physiol Res; 2015; 64(1):25-38. PubMed ID: 25194138
[TBL] [Abstract][Full Text] [Related]
28. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
Ferrario CM; Jessup J; Chappell MC; Averill DB; Brosnihan KB; Tallant EA; Diz DI; Gallagher PE
Circulation; 2005 May; 111(20):2605-10. PubMed ID: 15897343
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin-converting enzyme inhibition attenuates lipopolysaccharide-induced lung injury by regulating the balance between angiotensin-converting enzyme and angiotensin-converting enzyme 2 and inhibiting mitogen-activated protein kinase activation.
Li Y; Zeng Z; Li Y; Huang W; Zhou M; Zhang X; Jiang W
Shock; 2015 Apr; 43(4):395-404. PubMed ID: 25768373
[TBL] [Abstract][Full Text] [Related]
30. ACE2, a promising therapeutic target for pulmonary hypertension.
Shenoy V; Qi Y; Katovich MJ; Raizada MK
Curr Opin Pharmacol; 2011 Apr; 11(2):150-5. PubMed ID: 21215698
[TBL] [Abstract][Full Text] [Related]
31. A novel ACE2 activator reduces monocrotaline-induced pulmonary hypertension by suppressing the JAK/STAT and TGF-β cascades with restored caveolin-1 expression.
Haga S; Tsuchiya H; Hirai T; Hamano T; Mimori A; Ishizaka Y
Exp Lung Res; 2015 Feb; 41(1):21-31. PubMed ID: 25275723
[TBL] [Abstract][Full Text] [Related]
32. CYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent.
Sodhi K; Wu CC; Cheng J; Gotlinger K; Inoue K; Goli M; Falck JR; Abraham NG; Schwartzman ML
Hypertension; 2010 Nov; 56(5):871-8. PubMed ID: 20837888
[TBL] [Abstract][Full Text] [Related]
33. Effect of Simvastatin on 5-HT and 5-HTT in a Rat Model of Pulmonary Artery Hypertension.
Jiang X; Yuan L; Li P; Wang J; Wang P; Zhang L; Sun B; Sun W
Cell Physiol Biochem; 2015; 37(5):1712-24. PubMed ID: 26544069
[TBL] [Abstract][Full Text] [Related]
34. Chronic infusion of enalaprilat into hypothalamic paraventricular nucleus attenuates angiotensin II-induced hypertension and cardiac hypertrophy by restoring neurotransmitters and cytokines.
Kang YM; Zhang DM; Yu XJ; Yang Q; Qi J; Su Q; Suo YP; Yue LY; Zhu GQ; Qin DN
Toxicol Appl Pharmacol; 2014 Feb; 274(3):436-44. PubMed ID: 24342267
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin-Converting Enzyme 2 (ACE2) Signaling in Pulmonary Arterial Hypertension: Underpinning Mechanisms and Potential Targeting Strategies.
Papavassiliou KA; Gogou VA; Papavassiliou AG
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139269
[TBL] [Abstract][Full Text] [Related]
36. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
[TBL] [Abstract][Full Text] [Related]
37. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
[TBL] [Abstract][Full Text] [Related]
38. ACE2 activity was increased in atherosclerotic plaque by losartan: Possible relation to anti-atherosclerosis.
Zhang YH; Hao QQ; Wang XY; Chen X; Wang N; Zhu L; Li SY; Yu QT; Dong B
J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):292-300. PubMed ID: 25070352
[TBL] [Abstract][Full Text] [Related]
39. Tissue-specific regulation of angiotensin-converting enzyme by angiotensin II and losartan in the rat.
Metsärinne KP; Helin KH; Saijonmaa O; Stewen P; Sirviö ML; Fyhrquist FY
Blood Press; 1996 Nov; 5(6):363-70. PubMed ID: 8973755
[TBL] [Abstract][Full Text] [Related]
40. Dissociation between the circulating renin-angiotensin system and angiotensin II receptors in central losartan-induced hypertension.
Sugawara AM; Vendramini RC; Barbosa SP; Brunetti IL; Menani JV; De Luca LA
Braz J Med Biol Res; 2002 Sep; 35(9):1069-74. PubMed ID: 12219178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
